Lexicon Pharmaceuticals, Inc. (LXRX) NASDAQ
1.67
+0.065(+4.06%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.67
+0.065(+4.06%)
Currency In USD
| Market Cap | 417.51M |
| Enterprise Value | 445.42M |
| P/E Ratio | -11.71 |
| PEG Ratio | -0.44 |
| Price/Sales Ratio | 13.8 |
| Price/Book Ratio | 5.48 |
| Enterprise/Revenue | 14.36 |
| Enterprise/EBITDA | -16.76 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.01 |
| Operating Margin | -0.98 |
| Return On Assets | -0.27 |
| Return On Equity | -0.42 |
| Revenue | 49.8M |
| Revenue/Share | 0.14 |
| Gross Profit | 49.53M |
| EBITDA | -48.29M |
| Net Income | -50.34M |
| Diluted EPS | -0.14 |
| Total Cash | 96.23M |
| Total Cash/Share | 0.26 |
| Total Debt | 62.24M |
| Total Debt/Equity | 0.58 |
| Current Ratio | 4.88 |
| Book Value Per Share | 0.3 |
| 52-Week Change | 223.69 |
| 52-Week High | 1.83 |
| 52-Week Low | 0.45 |
| Moving Average 50 Days | 1.51 |
| Moving Average 200 Days | 1.3 |
| Average Volume | 2.98M |
| Shares Outstanding | 423.68M |
| % Held by Institutions | 71.66 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | May 21, 2015 |